Day One continues to offer a free version of its journaling app for iPhone, iPad, and Mac. Apple’s Journal app is the better free option if you want to capture from more than one device or add more ...

Now that the Supreme Court has struck down Trump's "emergency" tariffs, will the government refund the billions of dollars it unlawfully collected? And as Trump turns to other tariff authorities, how ...

Microsoft’s Xbox Game Pass just added a new day-one game to the library of the subscription service, and it is the best day-one game of 2026 so far. As a day-one game, this new addition is limited to ...

Servier agreed to acquire Day One Biopharmaceuticals for $2.5 billion in a push to expand its rare oncology portfolio. Servier will pay $21.50 a share in cash, representing a 68% premium to Day One’s ...

U.S. cancer drug developer Day One Biopharmaceuticals (DAWN) has agreed to be acquired by French pharmaceutical group Servier in an all-cash deal worth nearly $2.5B, according to a statement from the ...

March 6 (Reuters) - French drugmaker Servier said on Friday it would buy U.S.-based Day One Biopharmaceuticals (DAWN.O), opens new tab for ‌about $2.5 billion, expanding its brain tumor treatment ...

Use left and right arrow keys to seek audio. Microsoft's Xbox Game Pass has evolved since its inception, delivering day-one access to first-party releases and major third-party titles across consoles ...

Acquisition expands Day One’s pipeline with clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) targeting rare cancer adenoid cystic carcinoma (ACC) BRISBANE, Calif., Jan. 06, ...

From the moment 4-year-old Cameron first stepped out into Glimmer in Spyro 2, he knew video games were going to play a central role in the rest of his life. Though he never planned to make it the ...

Back in April 2024, I assigned Day One Biopharmaceuticals, Inc. (DAWN) stock a "Hold" rating in a note for the Seeking Alpha, covering the news that its lead asset tovorafenib had been awarded an ...

Before she was a VC, Masha Bucher worked in PR and marketing — an experience that has shaped the way she runs Day One Ventures. After years of working in communications — including executive roles ...

Mersana Therapeutics' decision earlier this year to go all-in on its antibody-drug conjugate Emi-Le appears to have paid off—at least based on the $285 million deal Day One Pharmaceuticals has signed ...